RT Journal Article
SR Electronic
T1 OCOsense™ smart glasses for analyzing facial expressions using optomyographic sensors
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.12.23289646
DO 10.1101/2023.05.12.23289646
A1 Archer, James
A1 Mavridou, Ifigeneia
A1 Stankoski, Simon
A1 Broulidakis, M. John
A1 Cleal, Andrew
A1 Walas, Piotr
A1 Fatoorechi, Mohsen
A1 Gjoreski, Hristijan
A1 Nduka, Charles
YR 2023
UL http://medrxiv.org/content/early/2023/05/16/2023.05.12.23289646.abstract
AB This article introduces the Emteq’s OCOsense™ smart glasses equipped with a novel non-contact OCO™ sensor technology for measuring facial muscle activation and expressions based on high resolution tracking of skin movement. We demonstrate that the OCO™ sensor technology based on optomyography is a sensitive and accurate approach for assessing skin movement in 3 dimensions, providing a means for measuring the facial expressions used to assess emotional valence such as smile, frown, and eyebrow raise. We propose that glasses-based optomyography sensing has the potential to herald a paradigm shift in real-world facial expression monitoring, thus enabling real-time emotional analytics with healthcare and research applications.Competing Interest StatementDevelopment of the OCOsenseTM system was part-funded by grants awarded by the NIHR (NIHR PDA award; ref: II-LA-0814-20008) and Innovate UK (Investment accelerator. ref: 105207). The study was funded by Emteq Labs.Funding StatementDevelopment of the OCOsenseTM system was part-funded by grants awarded by the NIHR (NIHR PDA award; ref: II-LA-0814-20008) and Innovate UK (Investment accelerator. ref: 105207). The study was funded by Emteq Labs.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:East of England - Cambridge Central Research Ethics Committee gave ethical approval for this work (ref: 15/EE/0186) London - Riverside Research Ethics Committee gave ethical approval for this work (ref: 22/LIO/0415), dated 15/07/2022.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors